chrisvoncsefalvay/vaers-outcomes huggingface dataset:
now experiencing chest pain; he is having a hard time walking; muscle pain; pain at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 14 year-old male patient received bnt162b2 (BNT162B2), administration date 09Feb2022 (Lot number: FL3197) at the age of 14 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, ), administration date: 17May2021, when the patient was 14 years old, for Covid-19 immunization; Bnt162b2 (Dose: 2, ), administration date: 07Jun2021, when the patient was 14 years old, for Covid-19 immunization. The following information was reported: CHEST PAIN (non-serious) with onset 10Feb2022, outcome "not recovered", described as "now experiencing chest pain"; GAIT DISTURBANCE (non-serious) with onset 10Feb2022, outcome "unknown", described as "he is having a hard time walking"; MYALGIA (non-serious) with onset 10Feb2022, outcome "unknown", described as "muscle pain"; VACCINATION SITE PAIN (non-serious) with onset 10Feb2022, outcome "unknown", described as "pain at the injection site". Therapeutic measures were taken as a result of chest pain, gait disturbance, myalgia, vaccination site pain.  Additional information: It was reported She says she does not have her son's vaccine card with her to provide NDC/LOT/EXP for the first two doses. Stated her son started having chest pain this morning, and when she called him he said he still has pain but did not say if it was worse or the same. She says she told him to take regular Tylenol that she has at home and put some ice on the pain on his leg, which is muscle pain on the right side. She says he is having a hard time walking and putting pressure on it, he has pain that is pretty bad pain. She says the chest pain, muscle pain, and injection site pain all started today because yesterday when she asked he said nothing hurt, it started this morning. She also stated that the whole family got COVID, and they had all got booster, and her son got to 6 months already so just in case, he got COVID booster. Caller clarifies that they had all gotten the booster dose last month except her son, and says then we all got infected, in the last couple weeks ago the family all tested positive except him.   No follow-up attempts are possible. No further information is expected.
"Staff member received 2nd dose Covid vaccine at 1355, began experiencing what she described as "similar to first dose"" (unreported) tingling in left arm approx. 10 minutes after receiving vaccine in Left arm. This progressed to tingling in her left leg/foot and 'weakened' left arm and left chest tightness 25 minutes after receiving vaccine. She reported s/s to IOH Lead at that time and monitoring began, Benadryl 25mg given P.O. BP at 1435 135/84, HR 90, Pox 100%, At 1445 Staff members reported improved s/s in arm, but right foot tingling. BP 124/79, HR 90, Pox 100%. At 1455 No s/s left arm or leg, no further chest tightness. BP 123/83, HR 95, Pox 100%. 1500 After standing for 5 minutes, BP 126/90, HR 96, Po 99%. Staff member stated she was ready to return to work. She will call fiancé to pick her up from work."
There was a slight reaction to the injection site with a little inflammation and redness and slight itching.
I had rashes, hives and redness full face  for 2 to 3 days after first dose....they started 4 fours after the vaccine
Patient was given Pfizer as a first vaccination, then given Moderna inadvertently for the second vaccination.   Patient had no symptoms immediately after vaccination.
had a surgery on 30 March 2021; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (had a surgery on 30 March 2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced SURGERY (had a surgery on 30 March 2021). The patient was treated with OXYCODONE at an unspecified dose and frequency. At the time of the report, SURGERY (had a surgery on 30 March 2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant treatment was provided. Patient called on 5-April-2021 to ask if there was an interaction between the Moderna COVID-19 vaccine and surgical procedure.  She had a surgery on 30-March-2021 and She was put on stool softener, Oxycodone, and antibiotics after the surgery.  She received her first vaccine on 12-March-2021, and she was schedule for her second vaccine on  9-April-2021.  She wanted to know if the surgery and the medicine she was taking will have an effect on the vaccine scheduled on 9April.
Approximately 2 weeks after the 2nd COVID vaccination was given (9/10/21), patient has developed daily frontal headaches with both photophobia and phonophobia. He gets approximately 2-3 hours relief from Tylenol before the headache returns.
Development of stiff knee joints about 1 month following second dose.  Has not resolved 3 months later.
Severe polymyalgias in large muscle groups, greatest lower back and lats, also both shoulders; decreased appetite. Symprtoms most severe 1 day post-vaccination then gradually abated over total of 4 days. treated with pain medication and heat
Post vax, the pt complained of lightheadness, abdominal pain, and sore throat.
RAPID PALPITATIONS AFTER AWAENKENING IN THE MORNING WORSE MIDDAY THEN STOPPED AROUND 5 PM
Lloss of appetite; Myalgia; Arthralgia; Fatigue; Headache; Fever; Left arm injection site pain; A spontaneous report was received from a healthcare professional concerning a 64-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events myalgia, arthralgia, fatigue, headache, loss of appetite, fever (101.5 °f) and left arm injection site pain.  The patient's medical history included Covid-19 and tested positive for 44 days.( Mar 2020).The patient also had a history of heart surgery -mitral valve repair( Sep 2020). No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient experienced  myalgia, arthralgia, fatigue, headache, loss of appetite, fever (101.5 °f) and  left arm injection site pain.The patient felt better on26 Jan 2021.  Lab information included body temperature which was 101.5 F on 23 Jan 2021.  Treatment details included Tylenol 1,000mg every 4 hours and Advil 600mg every 6 hours..  Action taken with mRNA-1273 in response to the events was Unknown.  The outcome of events-myalgia, arthralgia, fatigue, headache, loss of appetite, fever (101.5°f) and  left arm injection site pain- was considered to be recovering/resolving.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
she gave the Pentacel part of the vaccine and missed the HIB part for the child with no AE; Initial information received on 10-Dec-2020 regarding an unsolicited valid non-serious case from an other health professional.  This case involves child patient of an unknown age who received part of the vaccine and missed the hib (Haemophilus b) part (product preparation issue), while the patient received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  No concomitant medication was reported.   On an unknown date, the patient received 0.5 mL of dose once a day of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot number and expiry date unknown) via unknown route for prophylactic vaccination.  This was an actual medication error due to inappropriate reconstitution technique (PT: product preparation issue) (latency unknown).  No laboratory data reported.  At the time of reporting, no adverse event was reported to the patient.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There would be no information regarding batch number for the case.
This spontaneous report as received from a consumer refers to herself, a 64 year old female patient with dermerol allergy and penicillin allergy. On 28-OCT-2013 the patient was vaccinated with ZOSTAVAX dose 1, 0.65 ml (route and lot number unknown). Concomitant therapies included Synthroid, Primperam, Cymbalta and Lisinopril. On 29-OCT-2013, 1 day after onset of therapy the patient experienced an injection-site reaction. On Tuesday, 29-Oct-2013, she experienced a spot on her arm that was about an inch wide that was warm and hard. Then on Wednesday, 30-OCT-2013, it expanded by 2 inches and its warm and hard. The patient took some Advil on Tuesday for treatment. The outcome of spot on her arm that was warm and hard was reported as not recovered/not resolved. The reporter's relatedness of spot on her arm that was warm and hard to ZOSTAVAX is unknown. Additional information has been requested.
this was an influenza vaccine.my shoulder and arm felt an intense burning sensation when I got the vaccine and the shoulder and  upper arm have been hurting ever since.feels like the arm was pulled out of its socket and some ligaments were damaged.intense twinges of pain when moved certain ways and clicking that wasn?t there before.went to my doctor a week and a half after as it was not getting better and was making it very hard to sleep and do normal activities.
Due to the shingles, my nerve ending discomfort was still there after I got my booster the pain became worse. My doctor put me on tramadol and something else. one was for pain, and one was for nerves.
Iz given left arm - swollen, size of orange, no pus. Resolved with Benadryl
Started to feel intensely itchy the evening of the 17th as well as having the urticaria symptoms. Received a steroid shot on the 19th when I visited urgent care. PA prescribed medrol dosepack and hydroxyzine. Finished course of dosepack but still having same symptoms just not as intensely itchy as was initially.  Skin is still highly reactive to any type of touch as of today, the 19th of January.
Patient had first dose of HPV-9 vaccine at 4:56pm on 6/7/18 and had a seizure episode at 10:30pm that night per mom. Patient have a history of seizure and last seizure episode was April 2018 per mom.
Irregular heart rate.   Returned to regular heart rate around June 1.     Experienced heavy fatigue  april1-2
Received the vaccine that was on the counter in a punctured vial since 16Jul2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the vaccine that was on the counter in a punctured vial since 16Jul2021) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the vaccine that was on the counter in a punctured vial since 16Jul2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received the vaccine that was on the counter in a punctured vial since 16Jul2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.
The evening the patient received the vaccine, as well as, the following morning, patient reported he had tongue swelling and difficulty speaking. The patient had family members observe him and the adverse events resolved.
got sick with Bronchopneumonia; This is a spontaneous report from a contactable consumer (patient) reported for herself from a Pfizer sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 02Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that, patient was scheduled for a second dose due on 25Mar21, but because of the bad weather, she cancelled her schedule. She was rescheduled by her facility on 12Apr21, but she got sick with bronchopneumonia, bronchial trouble. She was at the risk as having the first shot. Patient treatment received for adverse events included: azithromycin, Prednisone, steroids and antibiotics. The outcome of the events was unknown.  QR Comment : Reason of delay: Daily spike of incoming calls due to COVID19 vaccine.  Follow up attempts are needed. Further information is expected.
NO symptoms after Vaccine Dose #1  1 week after Vaccine Dose #2 , I experienced a very  offensive metallic/chemical taste and smell in my mouth and nasal passages.  This then increased in food item's that I normally eat and had no  prior adverse affects.  Also, chemical items such as laundry soaps, dish soaps, and other cleaning products give me such a nasty smell each time I walk by the area these are located.  This has made an huge impact on my day to day living.   I am unable to enjoy foods and drinks.   I can not clean my house without having such side effects.  When I am bathing or using other soaps, I can barely stand the odor.  It is so offensive. 20+ weeks after my 2nd dose,  the symptoms still continue.  It has changed my quality of life.  I am afraid I have been permanently damaged in my nasal and taste bud area.
pt recv 21SEP95&26DEC95 pt devel hundreds of lesions all over body;pt daycare had an outbreak of varicella the wk before the pt sx began;pt was seen by the MD who confirmed a dx of varicella;
came down with cough; he came down with cold; he was on antibiotics so missed 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (came down with cough), NASOPHARYNGITIS (he came down with cold) and PRODUCT DOSE OMISSION ISSUE (he was on antibiotics so missed 2nd dose) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (came down with cough), NASOPHARYNGITIS (he came down with cold) and PRODUCT DOSE OMISSION ISSUE (he was on antibiotics so missed 2nd dose). At the time of the report, COUGH (came down with cough), NASOPHARYNGITIS (he came down with cold) and PRODUCT DOSE OMISSION ISSUE (he was on antibiotics so missed 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information were not reported. Treatment information were not reported.
Moderna COVID-19 Vaccine EUA Fever, headaches, tired, vomitting, no appetite
One day post vax, the pt became very sleepy and had a decreased appetite. Four days post vax, the pt developed an ear infection. The pt was treated with Ceftin.
Red warm to touch blister, happen sometime after vaccine dtap, cellulitis with freezer burn, local reaction to Dtap. Keflex 250mg, Benadryl.
pt recv vax 9MAY97 & 19MAY97 pt exp severe joint pain & fever between 100 & 103 which lasted 10 days;
I have been a regular exercise and heart healthy man for several years. My cholesterol levels were not dangerously high and a recent LDL lab was 128. On 11/4/21,  I got my Pfizer booster shot and developed shortness of breath and chest tightness on 12/05/21 while doing a physical workouts in our community gym and got better after I stopped my workout.  The symptom started to show up during normal walk in next days and even got worse at showers as well. I went to a local health care facility and ended up with a stent in my right coronary artery.  I strongly believe that this immediate episode happened due to my booster shot. Otherwise I was a roll model to our community youngsters for daily activities of workouts, playing soccer or basketball at least 3 to 4 days a week. I want CDC to do more studies even in the minority population who complains about complications of covid vaccinations.  I will available on my phone (NUMBER) if anybody from CDC wants to talk with me regarding my case.
1526 PCV 20 IM administered by CMA in left deltoid (Lot FW6028 / NDC 0005-2000-01 / Manufacturer Wyeth). At 1558 CMA completed post vaccine check and notified RN of Pt c/o tingling on lips after receiving vaccine. Vital signs taken by this RN at 1400 BP 139/76 HR 76. Pt AOx 3 with clear speech, non-labored breathing, no distress noted. Pt reports tingling on lips that began about 10 minutes after receiving PCV 20 - tingling currently improving. Pt with Hx of Bell's Palsy in 2007 - has never had tingling sensation before. Dr. notified. 1614 Dr. presented to exam room to assess Pt. Pt cleared to be discharged by PCP. EC precautions given to Pt by RN. Pt voiced understanding and left clinic with steady gait and no distress noted.
eyes and tongue swelling, light headiness, 1 epi given, transfer pt to ED
This spontaneous report was received from a nurse refers to 12-month-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 31-AUG-2017, the patient was vaccinated with improperly stored M-M-R II (dosing details were not reported) (lot # M045392, expiry date: 17-NOV-2018) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MRK). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054: Original Case: 1709USA000054.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown demographics. The patients' pertinent medical histories, drug reactions or allergies and concomitant medications were not reported. On unspecified dates, the patients received an improperly stored doses of RECOMBIVAX HB injection (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. The administered doses of vaccine were exposed to a temperature between 32 degrees Fahrenheit (F) and 36 degrees Fahrenheit (F), with the lowest temperature of 33 degrees Fahrenheit (F), for unknown period of time. No previous temperature excursion was reported. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA000338: US-009507513-1703USA000337: US-009507513-1703USA000335: US-009507513-1703USA000336:
This case was reported by a consumer and described the occurrence of autism in a 4-year-old male subject who was vaccinated with DTaP (SmithKline). A physician or other health care professional has not verified this report. In June 2002 the subject received 1st dose of DTaP (unknown) series. Dates of other vaccinations were not provided. At an unspecified time after vaccination, the mother reported that her son "never talked" but physically never exhibited signs of autism like pounding on the walls or rocking. He would "blurt out one word every six months." January 2007, 4 and one-half years after vaccination with DTaP, the subject was diagnosed with autism. The mother did not have the vaccination record but she believes that he received SmithKline DTaP vaccine. The mother reported that the events were disabling and jeopardized the subject or required intervention. She also believes that the autism is related to one or more of his vaccines but she does not know which vaccine. She also reported that another son developed autism. See GSK number A0721950A for details of this case. At the time of reporting the events were unresolved.
a patient was administered a dose of Havrix that was expired; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis.   On 23-JUN-2023, the patient received Havrix. On 23-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: a patient was administered a dose of Havrix that was expired). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 21-AUG-2023 The reporter was a Medical Assistant. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. The reporter reported that a patient was administered a dose of Havrix that was expired, which led to expired vaccine used.